查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1916508

全球整形手術市場：市場規模、市場份額、成長率、行業分析、按類型、應用和地區劃分的考慮因素以及未來預測（2026-2034）

Cosmetic Surgery Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 178 Pages | 商品交期: 請詢問到貨日

價格

整形手術市場成長因素

預計2025年全球整形手術市場規模將達591.3億美元，2026年將成長至613.2億美元，到2034年將達到833.3億美元。在預測期（2026-2034年）內，其複合年增長率（CAGR）為3.50%。北美地區引領整形手術市場，預計2025年將佔據30.70%的市場。這主要得益於北美地區較高的手術量、先進的美容技術以及消費者日益增長的改善自身外觀的需求。

美容手術包括隆乳、抽脂、隆鼻和腹部整形等外科手術，以及肉毒桿菌注射、皮膚填充劑注射、雷射除毛和非手術減脂等非手術治療。全球患者需求成長的驅動因素包括可支配收入的增加、社交媒體的影響以及各個年齡層對美容治療日益增長的接受度。

市場驅動因素

人們對自身外觀的日益關注以及皮膚相關問題的日益增加是推動市場擴張的關鍵因素。男女對美容手術的接受度不斷提高，以及對微創手術的興趣日益濃厚，持續推動著手術數量的增長。根據國際美容整形外科學會統計，2022年全球將進行約250萬例肉毒桿菌注射，反映出市場對非手術臉部年輕化療法的強烈需求。

能量型設備和注射劑的技術進步也帶來了更好的治療效果和更短的恢復時間，鼓勵更多患者尋求美容手術。醫療旅遊的蓬勃發展也促進了市場成長，巴西、墨西哥、泰國、馬來西亞、波蘭和哥斯達黎加等國家因其相對較低的治療費用和廣泛的專業診所網絡而成為熱門目的地。

市場限制因子

高昂的治療費用是推廣美容手術的主要障礙。根據美國美容整形外科學會2022年的報告，美國隆乳手術的平均醫師費用約為4,617美元，腹部整形手術的平均醫師費用約為7,465美元。先進的雷射和射頻（RF）設備的使用進一步增加了治療成本，使其成為許多地區的經濟挑戰。

此外，填充劑相關的副作用（例如瘀傷、色素沉著和發炎反應）也讓一些患者望而卻步。而且，美容手術通常不在保險範圍內，導致消費者需要承擔更高的自付費用。

市場機會

大型公司對醫療美容領域的投資不斷增加，創造了成長機會。 2022年6月，博士倫收購了Solta Medical，進一步拓展了其醫療美容產品組合。各公司正致力於創新設備的研發和新型注射劑配方的開發，以提高患者的舒適度和臨床療效。

技術提供者與美容診所之間合作的加強也推動了新療法的普及。新興市場診所網路的擴張和宣傳活動的增加，預計將使更多人能夠獲得美容服務。

市場挑戰

美容設備和注射的監管審批流程仍然漫長。美國食品藥物管理局 (FDA) 和歐洲藥品管理局 (EMA) 等監管機構要求提供大量的臨床證據，這增加了研發成本並延遲了產品上市。與身體形象認​​知和社會壓力相關的倫理問題也對市場的長期永續性構成挑戰。

由於診所監管不力以及從業人員培訓不足，安全問題進一步削弱了消費者的信任，尤其是在醫療旅遊市場。

整形手術市場趨勢

男性接受整形手術的次數正在快速增加。根據國際美容整形外科學會 (ISAPS) 的數據，2022 年全球約有 200 萬例男性整形手術（例如植髮、抽脂和隆鼻）。由於注射類美容項目恢復期短、效果隱蔽，男性對這類項目的需求也不斷增長。

由於恢復時間短、併發症風險低，非手術治療的成長速度超過了手術治療。諸如皮膚填充劑、肉毒桿菌注射和雷射換膚等療程在職場人士和年輕消費者中越來越受歡迎。

依細分市場分析

依療程分析

到2025年，手術療程將佔據79.01%的市場份額，這主要得益於隆乳、抽脂和隆鼻等療程的持續有效性。 2022年，全球約進行了190萬例美容手術，其中抽脂手術約40萬例。

由於注射類和能量型療法的日益普及，預計非手術治療的成長速度將更快。 2023年1月，高德美公司推出了一種名為 "FACE" 的皺紋檢測技術，旨在提高注射治療的效果。

性別

女性引領市場，預計到2026年將維持85.53%的市場份額，主要得益於她們對隆乳手術和臉部年輕化治療的需求。 2022年，英國報告的隆乳手術超過2萬例。隨著人們對整形手術接受度的提高，男性接受手術的數量也穩定成長。

依年齡組

預計到2025年，35-50歲年齡組將佔據40.3%的市場份額，這主要得益於她們對抗衰老和塑形治療的需求。由於隆鼻和隆乳手術需求增加，19-34歲年齡層的人正在增長。

依服務提供者劃分

截至2022年，全球約78.5%的外科手術由醫院和專科診所完成，這得益於先進的設備和門診治療的普及。由於手術費用低廉和健康旅遊的興起，醫療美容中心正在迅速發展。

區域展望

預計北美市場規模將在2025年達到181.5億美元，2026年達到188.3億美元，這主要得益於較高的可支配收入和美容儀器的日益普及。預計美國市場規模將在2026年達到174.7億美元。

預計歐洲市場規模將在2025年達到132.4億美元，主要得益於英國、德國和法國的強勁需求。預計德國到2026年將達到31.9億美元，法國到2025年將達到16.4億美元。

亞太地區到2026年將達到87億美元，主要由日本、中國和印度引領。預計日本市場規模到2026年將達到22.8億美元，中國為17億美元，印度為14.9億美元。

拉丁美洲地區到2025年將達到129.4億美元，主要受醫療旅遊和價格合理的整形手術服務的推動。中東和非洲地區的成長得益於對非手術治療需求的不斷增長。

目錄

第一章：引言

第二章：執行摘要

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 主要手術（手術和非手術）：按主要國家劃分（2022/2023）
  • 國家排名（手術和非手術，2022/2023）
  • 主要手術：按類別劃分（手術） （手術和非手術，2022/2023）
  • 主要手術項目：依性別劃分（手術與非手術，2022/2023）
  • 整形外科醫師數量：依主要國家/地區劃分（2022/2023）
  • 主要國家的醫療旅遊：外國病患人數排名前三的國家/地區
  • 主要手術項目：依適應症、費用、治療時間及治療次數劃分（手術及非手術）
  • 新產品發布：依主要公司劃分
  • 主要產業趨勢：併購、合作
  • 新冠疫情對市場的影響

第五章 全球整形外科市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依…劃分手術項目
    • 外科手術項目
      • 隆乳手術
      • 抽脂手術
      • 眼瞼整形手術
      • 腹部整形手術
      • 隆鼻手術
      • 其他
    • 非手術項目
      • 肉毒桿菌注射
      • 玻尿酸注射
      • 脫毛
      • 非手術減脂
      • 光子嫩膚
      • 其他
  • 市場分析、洞見與預測：依性別劃分
    • 女性
    • 男性
  • 市場分析、洞察與預測：依年齡組別劃分
    • 12歲以下18
    • 19-34
    • 35-50
    • 51-64
    • 65歲以上
  • 市場分析、洞察與預測：依服務提供者劃分
    • 醫院和專科診所
    • 水療中心及整形外科中心
  • 市場分析、洞察與預測：按地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章 北美整形外科市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲整形外科市場分析：洞察與預測預測（2021-2034）

  • 依國家劃分
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家

第八章 亞太地區整形外科市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 中國
    • 印度
    • 日本
    • 韓國
    • 東南亞
    • 其他亞太國家

第九章 拉丁美洲整形外科市場分析：洞察與預測（2021-2034）

  • 依國家/地區
    • 巴西
    • 墨西哥
    • 其他拉丁美洲國家/地區

第十章 中東與非洲整形外科市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 埃及
    • 土耳其
    • 其他中東和非洲國家/地區

第十一章 競爭分析

  • 全球市佔率分析（2025）
  • 企業簡介
    • Bausch Health Companies Inc.
    • Johnson &Johnson Services, Inc.(MENTOR)
    • AbbVie Inc.
    • Cutera
    • Merz Pharma
    • GALDERMA
    • Sientra, Inc.
    • Cynosure
    • Apyx Medical
    • Long Island Plastic Surgical Group, PC
Product Code: FBI102628

Growth Factors of cosmetic surgery Market

The global cosmetic surgery market size was valued at USD 59.13 billion in 2025 and is projected to grow to USD 61.32 billion in 2026, reaching USD 83.33 billion by 2034, exhibiting a CAGR of 3.50% during the forecast period (2026-2034). North America dominated the cosmetic surgery market with a 30.70% market share in 2025, supported by high procedure volumes, advanced aesthetic technologies, and strong consumer awareness regarding appearance enhancement.

Cosmetic surgery includes both surgical procedures such as breast augmentation, liposuction, rhinoplasty, and abdominoplasty, and non-surgical treatments such as botulinum toxin, dermal fillers, laser hair removal, and non-surgical fat reduction. Rising disposable incomes, strong influence of social media, and increasing acceptance of aesthetic treatments across age groups are driving patient demand worldwide.

Market Drivers

The increasing focus on physical appearance and rising incidence of skin-related concerns are major drivers supporting market expansion. Growing acceptance of cosmetic enhancements among women and men, along with rising interest in minimally invasive procedures, continues to increase procedure volumes. According to the International Society of Aesthetic Plastic Surgery, approximately 2.5 million botulinum toxin procedures were performed globally in 2022, reflecting strong demand for non-surgical facial rejuvenation.

Technological advancements in energy-based devices and injectable formulations are also improving treatment outcomes and reducing recovery time, encouraging more patients to seek cosmetic procedures. Expanding medical tourism further contributes to market growth, with countries such as Brazil, Mexico, Thailand, Malaysia, Poland, and Costa Rica emerging as preferred destinations due to affordable treatment costs and availability of specialized clinics.

Market Restraints

High treatment costs remain a key barrier for widespread adoption. According to the Aesthetic Society 2022 report, the average surgeon fee for breast augmentation in the U.S. is around USD 4,617, while abdominoplasty costs approximately USD 7,465 per procedure. The use of advanced laser and radiofrequency devices further increases procedural costs, making affordability a challenge in several regions.

Adverse effects associated with fillers, including bruising, pigmentation, and inflammatory reactions, also deter some patients. Additionally, cosmetic procedures are typically not covered by insurance, increasing out-of-pocket expenses for consumers.

Market Opportunities

Increasing investments in medical aesthetics divisions by major companies are creating growth opportunities. In June 2022, Bausch Health launched Solta Medical, expanding its medical aesthetics portfolio. Companies are focusing on innovative device development and new injectable formulations to improve patient comfort and clinical outcomes.

Growing collaborations between technology providers and cosmetic clinics are also supporting adoption of novel procedures. Expansion of clinic networks in emerging markets and rising awareness campaigns are expected to increase access to aesthetic services across broader populations.

Market Challenges

Regulatory approval timelines remain lengthy for aesthetic devices and injectables. Regulatory bodies such as the U.S. FDA and European Medicines Agency (EMA) require extensive clinical evidence, which increases development costs and delays product launches. Ethical concerns related to body image perceptions and social pressure also present challenges for long-term market sustainability.

Safety concerns from unregulated clinics and poorly trained practitioners further affect consumer trust, especially in medical tourism markets.

Cosmetic Surgery Market Trends

Male participation in cosmetic procedures is increasing rapidly. According to ISAPS, around 2 million cosmetic procedures were performed on men globally in 2022, including hair transplantation, liposuction, and rhinoplasty. Demand for injectables among men is also rising due to minimal downtime and discreet results.

Non-invasive treatments are growing faster than surgical procedures due to shorter recovery times and lower complication risks. Procedures such as dermal fillers, botulinum toxin, and laser resurfacing are gaining preference among working professionals and younger consumers.

Segmentation Analysis

By Procedure

Surgical procedures dominated with 79.01% market share in 2025, supported by long-lasting results of breast augmentation, liposuction, and rhinoplasty. In 2022, approximately 1.9 million surgical cosmetic procedures were performed globally, including 0.4 million liposuction procedures.

Non-surgical procedures are expected to grow faster due to rising popularity of injectables and energy-based treatments. In January 2023, GALDERMA launched FACE wrinkle-detection technology to improve injectable treatment outcomes.

By Gender

Females dominated the market and are expected to hold 85.53% share in 2026, driven by breast procedures and facial rejuvenation treatments. In the U.K., over 20,000 breast augmentations were reported in 2022. Male procedures are growing steadily due to rising acceptance of cosmetic grooming.

By Age Group

The 35-50 years age group held 40.3% market share in 2025, driven by anti-aging treatments and body contouring procedures. The 19-34 years segment is growing due to rising rhinoplasty and breast enhancement demand.

By Provider

Hospitals and specialty clinics performed approximately 78.5% of procedures globally in 2022, supported by advanced equipment and outpatient treatment availability. Medical spas are expanding rapidly due to lower procedure costs and rising wellness tourism.

Regional Outlook

North America generated USD 18.15 billion in 2025 and USD 18.83 billion in 2026, driven by high disposable income and strong aesthetic device adoption. The U.S. reached USD 17.47 billion in 2026.

Europe reached USD 13.24 billion in 2025, with strong demand in the U.K., Germany, and France. Germany reached USD 3.19 billion in 2026, while France reached USD 1.64 billion in 2025.

Asia Pacific reached USD 8.70 billion in 2026, driven by Japan, China, and India. Japan reached USD 2.28 billion in 2026, China USD 1.70 billion, and India USD 1.49 billion.

Latin America reached USD 12.94 billion in 2025, driven by medical tourism and affordable surgical services. Middle East & Africa growth is supported by rising non-surgical procedure demand.

Competitive Landscape

Major companies including Bausch Health, Johnson & Johnson (MENTOR), AbbVie, GALDERMA, Merz Pharma, Cutera, and Cynosure lead through strong product portfolios and regulatory approvals. In June 2023, GALDERMA received FDA approval for Restylane Eyelight, while Cutera received approval for AviClear acne treatment. Strategic collaborations and global clinic partnerships continue to strengthen market positioning.

Conclusion

The cosmetic surgery market shows steady expansion from USD 59.13 billion in 2025 to USD 61.32 billion in 2026, with the market expected to reach USD 83.33 billion by 2034, growing at a CAGR of 3.50% during 2026-2034. Growth is supported by increasing acceptance of aesthetic procedures across both genders, rising influence of social media on beauty standards, and continuous technological advancements in surgical and non-surgical treatments. Surgical procedures dominated with 79.01% share in 2025, reflecting sustained demand for long-lasting outcomes such as breast augmentation and liposuction, while non-surgical treatments are expanding rapidly due to shorter recovery times and lower risks. Regionally, North America led with 30.70% share in 2025, supported by high procedure volumes and advanced aesthetic infrastructure, while Latin America and Asia Pacific are gaining momentum through medical tourism and rising disposable incomes. Although high procedure costs, regulatory approvals, and safety concerns present ongoing challenges, increasing R&D investments, expansion of medical spa networks, and product innovations by leading companies such as AbbVie, GALDERMA, Johnson & Johnson (MENTOR), and Bausch Health continue to strengthen market competitiveness and long-term demand for cosmetic surgery services worldwide.

Growth Rate CAGR of 3.50% from 2026-2034

Segmentation By Procedure

  • Surgical Procedures
    • Breast Augmentation
    • Liposuction
    • Eyelid Surgery
    • Abdominoplasty
    • Rhinoplasty
    • Others
  • Non-Surgical Procedures
    • Botulinum Toxin
    • Hyaluronic Acid
    • Hair Removal
    • Non-surgical Fat Reduction
    • Photo Rejuvenation
    • Others

By Gender

  • Female
  • Male

By Age Group

  • 18 Years and Younger
  • 19 to 34 Years
  • 35 to 50 Years
  • 51 to 64 Years
  • 65 Years & Above

By Provider

  • Hospitals & Specialty Clinics
  • Spas & Cosmetic Surgery Centers

By Region

  • North America (By Procedure, Provider, Gender, Age Group, and Country)
    • U.S.
    • Canada
  • Europe (By Procedure, Provider, Gender, Age Group, and Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific (By Procedure, Provider, Gender, Age Group, and Country/Sub-Region)
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Procedure, Provider, Gender, Age Group, and Country/Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Procedure, Provider, Gender, Age Group, and Country/Sub-Region)
    • Egypt
    • Turkey
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Key Procedures, By Key Countries (Surgical & Non-Surgical), 2022/2023
  • 4.2. Ranks of Countries, By Key Procedures (Surgical & Non-Surgical), 2022/2023
  • 4.3. Key Procedures, By Categories (Surgical & Non-Surgical), 2022/2023
  • 4.4. Key Procedures, By Gender (Surgical & Non-Surgical), 2022/2023
  • 4.5. Plastic Surgeons, By Key Countries 2022/2023
  • 4.6. Medical Tourism in Key Countries, By Top 3 Countries of Foreign Patients
  • 4.7. Key Procedures, By Indication, By Cost, By Length of Procedure, By Number of Treatment (Surgical & Non-Surgical)
  • 4.8. New Product Launches, By Key Players
  • 4.9. Key Industry Developments- Mergers, Partnerships, & Acquisitions
  • 4.10. Impact of COVID-19 on the Market

5. Global Cosmetic Surgery Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Procedures
    • 5.1.1. Surgical Procedures
      • 5.1.1.1. Breast Augmentation
      • 5.1.1.2. Liposuction
      • 5.1.1.3. Eyelid Surgery
      • 5.1.1.4. Abdominoplasty
      • 5.1.1.5. Rhinoplasty
      • 5.1.1.6. Others
    • 5.1.2. Non-Surgical Procedures
      • 5.1.2.1. Botulinum Toxin
      • 5.1.2.2. Hyaluronic Acid
      • 5.1.2.3. Hair Removal
      • 5.1.2.4. Nonsurgical Fat Reduction
      • 5.1.2.5. Photo Rejuvenation
      • 5.1.2.6. Others
  • 5.2. Market Analysis, Insights and Forecast - By Gender
    • 5.2.1. Females
    • 5.2.2. Males
  • 5.3. Market Analysis, Insights and Forecast - By Age Group
    • 5.3.1. 18 and Younger
    • 5.3.2. 19 to 34 Years
    • 5.3.3. 35 to 50 Years
    • 5.3.4. 51 to 64 Years
    • 5.3.5. 65 Years and Above
  • 5.4. Market Analysis, Insights and Forecast - By Provider
    • 5.4.1. Hospitals & Specialty Clinics
    • 5.4.2. Spas & Cosmetic Surgery Centers
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Cosmetic Surgery Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Procedures
    • 6.1.1. Surgical Procedures
      • 6.1.1.1. Breast Augmentation
      • 6.1.1.2. Liposuction
      • 6.1.1.3. Eyelid Surgery
      • 6.1.1.4. Abdominoplasty
      • 6.1.1.5. Rhinoplasty
      • 6.1.1.6. Others
    • 6.1.2. Non-Surgical Procedures
      • 6.1.2.1. Botulinum Toxin
      • 6.1.2.2. Hyaluronic Acid
      • 6.1.2.3. Hair Removal
      • 6.1.2.4. Nonsurgical Fat Reduction
      • 6.1.2.5. Photo Rejuvenation
      • 6.1.2.6. Others
  • 6.2. Market Analysis, Insights and Forecast - By Gender
    • 6.2.1. Females
    • 6.2.2. Males
  • 6.3. Market Analysis, Insights and Forecast - By Age Group
    • 6.3.1. 18 and Younger
    • 6.3.2. 19 to 34 Years
    • 6.3.3. 35 to 50 Years
    • 6.3.4. 51 to 64 Years
    • 6.3.5. 65 Years and Above
  • 6.4. Market Analysis, Insights and Forecast - By Provider
    • 6.4.1. Hospitals & Specialty Clinics
    • 6.4.2. Spas & Cosmetic Surgery Centers
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Cosmetic Surgery Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Procedures
    • 7.1.1. Surgical Procedures
      • 7.1.1.1. Breast Augmentation
      • 7.1.1.2. Liposuction
      • 7.1.1.3. Eyelid Surgery
      • 7.1.1.4. Abdominoplasty
      • 7.1.1.5. Rhinoplasty
      • 7.1.1.6. Others
    • 7.1.2. Non-Surgical Procedures
      • 7.1.2.1. Botulinum Toxin
      • 7.1.2.2. Hyaluronic Acid
      • 7.1.2.3. Hair Removal
      • 7.1.2.4. Nonsurgical Fat Reduction
      • 7.1.2.5. Photo Rejuvenation
      • 7.1.2.6. Others
  • 7.2. Market Analysis, Insights and Forecast - By Gender
    • 7.2.1. Females
    • 7.2.2. Males
  • 7.3. Market Analysis, Insights and Forecast - By Age Group
    • 7.3.1. 18 and Younger
    • 7.3.2. 19 to 34 Years
    • 7.3.3. 35 to 50 Years
    • 7.3.4. 51 to 64 Years
    • 7.3.5. 65 Years and Above
  • 7.4. Market Analysis, Insights and Forecast - By Provider
    • 7.4.1. Hospitals & Specialty Clinics
    • 7.4.2. Spas & Cosmetic Surgery Centers
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.5.1. Germany
    • 7.5.2. U.K.
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Russia
    • 7.5.7. Rest of Europe

8. Asia Pacific Cosmetic Surgery Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Procedures
    • 8.1.1. Surgical Procedures
      • 8.1.1.1. Breast Augmentation
      • 8.1.1.2. Liposuction
      • 8.1.1.3. Eyelid Surgery
      • 8.1.1.4. Abdominoplasty
      • 8.1.1.5. Rhinoplasty
      • 8.1.1.6. Others
    • 8.1.2. Non-Surgical Procedures
      • 8.1.2.1. Botulinum Toxin
      • 8.1.2.2. Hyaluronic Acid
      • 8.1.2.3. Hair Removal
      • 8.1.2.4. Nonsurgical Fat Reduction
      • 8.1.2.5. Photo Rejuvenation
      • 8.1.2.6. Others
  • 8.2. Market Analysis, Insights and Forecast - By Gender
    • 8.2.1. Females
    • 8.2.2. Males
  • 8.3. Market Analysis, Insights and Forecast - By Age Group
    • 8.3.1. 18 and Younger
    • 8.3.2. 19 to 34 Years
    • 8.3.3. 35 to 50 Years
    • 8.3.4. 51 to 64 Years
    • 8.3.5. 65 Years and Above
  • 8.4. Market Analysis, Insights and Forecast - By Provider
    • 8.4.1. Hospitals & Specialty Clinics
    • 8.4.2. Spas & Cosmetic Surgery Centers
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.5.1. China
    • 8.5.2. India
    • 8.5.3. Japan
    • 8.5.4. South Korea
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Cosmetic Surgery Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Procedures
    • 9.1.1. Surgical Procedures
      • 9.1.1.1. Breast Augmentation
      • 9.1.1.2. Liposuction
      • 9.1.1.3. Eyelid Surgery
      • 9.1.1.4. Abdominoplasty
      • 9.1.1.5. Rhinoplasty
      • 9.1.1.6. Others
    • 9.1.2. Non-Surgical Procedures
      • 9.1.2.1. Botulinum Toxin
      • 9.1.2.2. Hyaluronic Acid
      • 9.1.2.3. Hair Removal
      • 9.1.2.4. Nonsurgical Fat Reduction
      • 9.1.2.5. Photo Rejuvenation
      • 9.1.2.6. Others
  • 9.2. Market Analysis, Insights and Forecast - By Gender
    • 9.2.1. Females
    • 9.2.2. Males
  • 9.3. Market Analysis, Insights and Forecast - By Age Group
    • 9.3.1. 18 and Younger
    • 9.3.2. 19 to 34 Years
    • 9.3.3. 35 to 50 Years
    • 9.3.4. 51 to 64 Years
    • 9.3.5. 65 Years and Above
  • 9.4. Market Analysis, Insights and Forecast - By Provider
    • 9.4.1. Hospitals & Specialty Clinics
    • 9.4.2. Spas & Cosmetic Surgery Centers
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Cosmetic Surgery Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Procedures
    • 10.1.1. Surgical Procedures
      • 10.1.1.1. Breast Augmentation
      • 10.1.1.2. Liposuction
      • 10.1.1.3. Eyelid Surgery
      • 10.1.1.4. Abdominoplasty
      • 10.1.1.5. Rhinoplasty
      • 10.1.1.6. Others
    • 10.1.2. Non-Surgical Procedures
      • 10.1.2.1. Botulinum Toxin
      • 10.1.2.2. Hyaluronic Acid
      • 10.1.2.3. Hair Removal
      • 10.1.2.4. Nonsurgical Fat Reduction
      • 10.1.2.5. Photo Rejuvenation
      • 10.1.2.6. Others
  • 10.2. Market Analysis, Insights and Forecast - By Gender
    • 10.2.1. Females
    • 10.2.2. Males
  • 10.3. Market Analysis, Insights and Forecast - By Age Group
    • 10.3.1. 18 and Younger
    • 10.3.2. 19 to 34 Years
    • 10.3.3. 35 to 50 Years
    • 10.3.4. 51 to 64 Years
    • 10.3.5. 65 Years and Above
  • 10.4. Market Analysis, Insights and Forecast - By Provider
    • 10.4.1. Hospitals & Specialty Clinics
    • 10.4.2. Spas & Cosmetic Surgery Centers
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.5.1. Egypt
    • 10.5.2. Turkey
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Bausch Health Companies Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products & services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Johnson & Johnson Services, Inc. (MENTOR)
      • 11.2.2.1. Overview
      • 11.2.2.2. Products & services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. AbbVie Inc.
      • 11.2.3.1. Overview
      • 11.2.3.2. Products & services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Cutera
      • 11.2.4.1. Overview
      • 11.2.4.2. Products & services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Merz Pharma
      • 11.2.5.1. Overview
      • 11.2.5.2. Products & services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. GALDERMA
      • 11.2.6.1. Overview
      • 11.2.6.2. Products & services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Sientra, Inc.
      • 11.2.7.1. Overview
      • 11.2.7.2. Products & services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. Cynosure
      • 11.2.8.1. Overview
      • 11.2.8.2. Products & services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. Apyx Medical
      • 11.2.9.1. Overview
      • 11.2.9.2. Products & services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. Long Island Plastic Surgical Group, PC
      • 11.2.10.1. Overview
      • 11.2.10.2. Products & services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 01: Global Cosmetic Surgery Market Revenue (USD billion) Forecast, By Procedures, 2021-2034
  • Table 02: Global Cosmetic Surgery Market Revenue (USD billion) Forecast, By Surgical Procedures, 2021-2034
  • Table 03: Global Cosmetic Surgery Market Revenue (USD billion) Forecast, By Non-Surgical Procedures, 2021-2034
  • Table 04: Global Cosmetic Surgery Market Revenue (USD billion) Forecast, By Gender, 2021-2034
  • Table 05: Global Cosmetic Surgery Market Revenue (USD billion) Forecast, By Age Group, 2021-2034
  • Table 06: Global Cosmetic Surgery Market Revenue (USD billion) Forecast, By Provider, 2021-2034
  • Table 07: Global Cosmetic Surgery Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 08: North America Cosmetic Surgery Market Revenue (USD billion) Forecast, By Procedures, 2021-2034
  • Table 09: North America Cosmetic Surgery Market Revenue (USD billion) Forecast, By Surgical Procedures, 2021-2034
  • Table 10: North America Cosmetic Surgery Market Revenue (USD billion) Forecast, By Non-Surgical Procedures, 2021-2034
  • Table 11: North America Cosmetic Surgery Market Revenue (USD billion) Forecast, By Gender, 2021-2034
  • Table 12: North America Cosmetic Surgery Market Revenue (USD billion) Forecast, By Age Group, 2021-2034
  • Table 13: North America Cosmetic Surgery Market Revenue (USD billion) Forecast, By Provider, 2021-2034
  • Table 14: North America Cosmetic Surgery Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 15: Europe Cosmetic Surgery Market Revenue (USD billion) Forecast, By Procedures, 2021-2034
  • Table 16: Europe Cosmetic Surgery Market Revenue (USD billion) Forecast, By Surgical Procedures, 2021-2034
  • Table 17: Europe Cosmetic Surgery Market Revenue (USD billion) Forecast, By Non-Surgical Procedures, 2021-2034
  • Table 18: Europe Cosmetic Surgery Market Revenue (USD billion) Forecast, By Gender, 2021-2034
  • Table 19: Europe Cosmetic Surgery Market Revenue (USD billion) Forecast, By Age Group, 2021-2034
  • Table 20: Europe Cosmetic Surgery Market Revenue (USD billion) Forecast, By Provider, 2021-2034
  • Table 21: Europe Cosmetic Surgery Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
  • Table 22: Asia Pacific Cosmetic Surgery Market Revenue (USD billion) Forecast, By Procedures, 2021-2034
  • Table 23: Asia Pacific Cosmetic Surgery Market Revenue (USD billion) Forecast, By Surgical Procedures, 2021-2034
  • Table 24: Asia Pacific Cosmetic Surgery Market Revenue (USD billion) Forecast, By Non-Surgical Procedures, 2021-2034
  • Table 25: Asia Pacific Cosmetic Surgery Market Revenue (USD billion) Forecast, By Gender, 2021-2034
  • Table 26: Asia Pacific Cosmetic Surgery Market Revenue (USD billion) Forecast, By Age Group, 2021-2034
  • Table 27: Asia Pacific Cosmetic Surgery Market Revenue (USD billion) Forecast, By Provider, 2021-2034
  • Table 28: Asia Pacific Cosmetic Surgery Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
  • Table 29: Latin America Cosmetic Surgery Market Revenue (USD billion) Forecast, By Procedures, 2021-2034
  • Table 30: Latin America Cosmetic Surgery Market Revenue (USD billion) Forecast, By Surgical Procedures, 2021-2034
  • Table 31: Latin America Cosmetic Surgery Market Revenue (USD billion) Forecast, By Non-Surgical Procedures, 2021-2034
  • Table 32: Latin America Cosmetic Surgery Market Revenue (USD billion) Forecast, By Gender, 2021-2034
  • Table 33: Latin America Cosmetic Surgery Market Revenue (USD billion) Forecast, By Age Group, 2021-2034
  • Table 34: Latin America Cosmetic Surgery Market Revenue (USD billion) Forecast, By Provider, 2021-2034
  • Table 35: Latin America Cosmetic Surgery Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034
  • Table 36: Middle East & Africa Cosmetic Surgery Market Revenue (USD billion) Forecast, By Procedures, 2021-2034
  • Table 37: Middle East & Africa Cosmetic Surgery Market Revenue (USD billion) Forecast, By Surgical Procedures, 2021-2034
  • Table 38: Middle East & Africa Cosmetic Surgery Market Revenue (USD billion) Forecast, By Non-Surgical Procedures, 2021-2034
  • Table 39: Middle East & Africa Cosmetic Surgery Market Revenue (USD billion) Forecast, By Gender, 2021-2034
  • Table 40: Middle East & Africa Cosmetic Surgery Market Revenue (USD billion) Forecast, By Age Group, 2021-2034
  • Table 41: Middle East & Africa Cosmetic Surgery Market Revenue (USD billion) Forecast, By Provider, 2021-2034
  • Table 42: Middle East & Africa Cosmetic Surgery Market Revenue (USD billion) Forecast, By Country/Sub-region, 2021-2034

List of Figures

  • Figure 01: Global Cosmetic Surgery Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 02: Global Cosmetic Surgery Market Value Share (%), By Procedures, 2025 & 2034
  • Figure 03: Global Cosmetic Surgery Market Value Share (%), By Gender, 2025 & 2034
  • Figure 04: Global Cosmetic Surgery Market Value Share (%), By Age Group, 2025 & 2034
  • Figure 05: Global Cosmetic Surgery Market Value Share (%), By Provider, 2025 & 2034
  • Figure 06: Global Cosmetic Surgery Market Value Share (%), By Region, 2025 & 2034
  • Figure 07: North America Cosmetic Surgery Market Value (USD billion), by Procedures, 2025 & 2034
  • Figure 08: North America Cosmetic Surgery Market Value Share (%), by Procedures, 2025
  • Figure 09: North America Cosmetic Surgery Market Value (USD billion), by Gender, 2025 & 2034
  • Figure 10: North America Cosmetic Surgery Market Value Share (%), by Gender, 2025
  • Figure 11: North America Cosmetic Surgery Market Value (USD billion), by Age Group, 2025 & 2034
  • Figure 12: North America Cosmetic Surgery Market Value Share (%), by Age Group, 2025
  • Figure 13: North America Cosmetic Surgery Market Value (USD billion), by Provider, 2025 & 2034
  • Figure 14: North America Cosmetic Surgery Market Value Share (%), by Provider, 2025
  • Figure 15: North America Cosmetic Surgery Market Value (USD billion), by Country, 2025 & 2034
  • Figure 16: North America Cosmetic Surgery Market Value Share (%), by Country, 2025
  • Figure 17: Europe Cosmetic Surgery Market Value (USD billion), by Procedures, 2025 & 2034
  • Figure 18: Europe Cosmetic Surgery Market Value Share (%), by Procedures, 2025
  • Figure 19: Europe Cosmetic Surgery Market Value (USD billion), by Gender, 2025 & 2034
  • Figure 20: Europe Cosmetic Surgery Market Value Share (%), by Gender, 2025
  • Figure 21: Europe Cosmetic Surgery Market Value (USD billion), by Age Group, 2025 & 2034
  • Figure 22: Europe Cosmetic Surgery Market Value Share (%), by Age Group, 2025
  • Figure 23: Europe Cosmetic Surgery Market Value (USD billion), by Provider, 2025 & 2034
  • Figure 24: Europe Cosmetic Surgery Market Value Share (%), by Provider, 2025
  • Figure 25: Europe Cosmetic Surgery Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 26: Europe Cosmetic Surgery Market Value Share (%), by Country/Sub-region, 2025
  • Figure 27: Asia Pacific Cosmetic Surgery Market Value (USD billion), by Procedures, 2025 & 2034
  • Figure 28: Asia Pacific Cosmetic Surgery Market Value Share (%), by Procedures, 2025
  • Figure 29: Asia Pacific Cosmetic Surgery Market Value (USD billion), by Gender, 2025 & 2034
  • Figure 30: Asia Pacific Cosmetic Surgery Market Value Share (%), by Gender, 2025
  • Figure 31: Asia Pacific Cosmetic Surgery Market Value (USD billion), by Age Group, 2025 & 2034
  • Figure 32: Asia Pacific Cosmetic Surgery Market Value Share (%), by Age Group, 2025
  • Figure 33: Asia Pacific Cosmetic Surgery Market Value (USD billion), by Provider, 2025 & 2034
  • Figure 34: Asia Pacific Cosmetic Surgery Market Value Share (%), by Provider, 2025
  • Figure 35: Asia Pacific Cosmetic Surgery Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Cosmetic Surgery Market Value Share (%), by Country/Sub-region, 2025
  • Figure 37: Latin America Cosmetic Surgery Market Value (USD billion), by Procedures, 2025 & 2034
  • Figure 38: Latin America Cosmetic Surgery Market Value Share (%), by Procedures, 2025
  • Figure 39: Latin America Cosmetic Surgery Market Value (USD billion), by Gender, 2025 & 2034
  • Figure 40: Latin America Cosmetic Surgery Market Value Share (%), by Gender, 2025
  • Figure 41: Latin America Cosmetic Surgery Market Value (USD billion), by Age Group, 2025 & 2034
  • Figure 42: Latin America Cosmetic Surgery Market Value Share (%), by Age Group, 2025
  • Figure 43: Latin America Cosmetic Surgery Market Value (USD billion), by Provider, 2025 & 2034
  • Figure 44: Latin America Cosmetic Surgery Market Value Share (%), by Provider, 2025
  • Figure 45: Latin America Cosmetic Surgery Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 46: Latin America Cosmetic Surgery Market Value Share (%), by Country/Sub-region, 2025
  • Figure 47: Middle East & Africa Cosmetic Surgery Market Value (USD billion), by Procedures, 2025 & 2034
  • Figure 48: Middle East & Africa Cosmetic Surgery Market Value Share (%), by Procedures, 2025
  • Figure 49: Middle East & Africa Cosmetic Surgery Market Value (USD billion), by Gender, 2025 & 2034
  • Figure 50: Middle East & Africa Cosmetic Surgery Market Value Share (%), by Gender, 2025
  • Figure 51: Middle East & Africa Cosmetic Surgery Market Value (USD billion), by Age Group, 2025 & 2034
  • Figure 52: Middle East & Africa Cosmetic Surgery Market Value Share (%), by Age Group, 2025
  • Figure 53: Middle East & Africa Cosmetic Surgery Market Value (USD billion), by Provider, 2025 & 2034
  • Figure 54: Middle East & Africa Cosmetic Surgery Market Value Share (%), by Provider, 2025
  • Figure 55: Middle East & Africa Cosmetic Surgery Market Value (USD billion), by Country/Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Cosmetic Surgery Market Value Share (%), by Country/Sub-region, 2025
  • Figure 57: Global Cosmetic Surgery Market Share (%), 2025